Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
18
|
| pubmed:dateCreated |
1995-2-14
|
| pubmed:abstractText |
Cytotoxic T lymphocyte (CTL) epitopes are naturally processed peptides bound and presented by major histocompatibility (MHC) class I molecules. Since they are expressed at the cell surface in sufficient amounts to be recognized by CTL, it is generally believed, and in some cases demonstrated, that they bind efficiently to MHC class I molecules in vivo. Based on this knowledge, candidate CTL epitopes are now searched for by identifying peptides that efficiently bind to MHC class I molecules in vitro. We analysed whether this approach is valid by systematically investigating the relationship between MHC class I-peptide binding and peptide immunogenicity. Fifteen peptides that represent known CTL epitopes were tested for their MHC class I binding ability. In a comparative study with 83 peptides that bear the appropriate MHC class I allele-specific motifs but do not contain known CTL epitopes, the CTL epitope-bearing peptides showed the highest binding affinity for MHC class I. This was true for two MHC class I alleles in two different assay systems that monitor peptide-MHC class I binding. Furthermore, selected motif-bearing Kb binding peptides were used to induce peptide-specific CTL responses in mice. Only a subset of the high affinity Kb binding peptides induced reproducible peptide-specific CTL responses, whereas none of the low affinity Kb binding peptides induced a response. Taken together, these results indicate that efficient peptide-MHC class I binding is required for immunogenicity. Vice versa, immunogenicity is not guaranteed by efficient peptide-MHC class I binding, implying that additional factors are involved. Nevertheless, selection of candidate CTL epitopes on the basis of MHC class I binding seems valid. Our data indicate that, although an excess of peptides might be selected, the chance of missing immunogenic peptides is minimal.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0161-5890
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
31
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1391-401
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:7823965-Amino Acid Sequence,
pubmed-meshheading:7823965-Animals,
pubmed-meshheading:7823965-Antigen-Presenting Cells,
pubmed-meshheading:7823965-Cytotoxicity, Immunologic,
pubmed-meshheading:7823965-Epitope Mapping,
pubmed-meshheading:7823965-H-2 Antigens,
pubmed-meshheading:7823965-Mice,
pubmed-meshheading:7823965-Mice, Inbred C57BL,
pubmed-meshheading:7823965-Molecular Sequence Data,
pubmed-meshheading:7823965-Peptides,
pubmed-meshheading:7823965-Protein Binding,
pubmed-meshheading:7823965-Structure-Activity Relationship,
pubmed-meshheading:7823965-T-Lymphocytes, Cytotoxic
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity.
|
| pubmed:affiliation |
Department of Immunohematology and Blood Bank, University Hospital Leiden, The Netherlands.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|